Bard wins FDA approval for LifeStream covered iliac stent - Mass Device

Mass Device
Bard wins FDA approval for LifeStream covered iliac stent
Mass Device
C.R. Bard's LifeStream covered iliac stent C.R. Bard (NYSE:BCR) said today that it won pre-market approval from the FDA for its LifeStream covered iliac stent for treating peripheral artery disease. The PMA covers the treatment of atherosclerotic ...